Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
Hepatology2015Vol. 63(1), pp. 284–306
Citations Over TimeTop 1% of 2015 papers
Anna S. Lok, Brian J. McMahon, Robert S. Brown, John B. Wong, Ahmed T. Ahmed, Wigdan Farah, Jehad Almasri, Fares Alahdab, Khalid Benkhadra, Mohamed A. Mouchli, Siddharth Singh, Essa A. Mohamed, Abd Moain Abu Dabrh, Larry J. Prokop, Zhen Wang, M. Hassan Murad, Khaled Mohammed
Abstract
Most of the current literature focuses on the immune active phases of chronic HBV infection; decision-making in other commonly encountered and challenging clinical settings depends on indirect evidence.
Related Papers
- How severe is chronic hepatitis with HCV genotype 1b? A study of 1,220 cases on the waiting list for antiviral therapy in Romania.(2011)
- Research progress of antiviral therapy on chronic hepatitis C(2013)
- [Current issues in antiviral therapy of chronic hepatitis B and C].(2010)
- [A report from the second symposium on the hots and difficult points during antiviral therapy for chronic hepatitis B].(2011)
- → Pharmaco-economical analysis and its applying to economical efficacy evaluation of different antiviral therapy schemes of chronic hepatitis c(2006)